NCT06443567

Brief Summary

To describe and measure diastolic and systolic femoral arterial pressure during medical cardiac arrest. To define baseline measures. To describe and measure arterial blood pressure after placement of an ITD device. To observe the diastolic pressure immediately prior to return of spontaneous circulation. To quantify and describe the effects of intravenous adrenaline on arterial blood pressure in cardiac arrest.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 5, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

September 25, 2025

Status Verified

September 1, 2025

Enrollment Period

3 months

First QC Date

May 30, 2024

Last Update Submit

September 23, 2025

Conditions

Keywords

impedance threshold deviceblood pressurecardiac arrest

Outcome Measures

Primary Outcomes (1)

  • systolic femoral invasive blood pressure

    3 mins average with CPR by LUCAS device

Secondary Outcomes (2)

  • femoral diastolic pressure

    3 mins average with CPR by LUCAS device

  • femoral arterial pressure, both systolic and diastolic

    3 mins average post placement of ICD device

Study Arms (1)

adult cardiac arrest

blood pressure measurement pre and post impedance threshold device placement

Device: impedance threshold device

Interventions

impedance threshold device (ResQPOD, Zoll) applied to airway

adult cardiac arrest

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (18+) suffering an out of hospital cardiac arrest (OHCA) by a presumed medical cause that have been deemed suitable to attempt resuscitation of. All individuals will be considered for inclusion in this study regardless of age, disability, gender reassignment, marriage, and civil partnership, pregnancy and maternity, race, religion and belief, sex, and sexual orientation except where the study inclusion and exclusion criteria EXPLICITLY state otherwise.

You may qualify if:

  • Adult patients (≥18years) in medical cardiac arrest
  • Deemed suitable to attempt resuscitation.

You may not qualify if:

  • Prisoners
  • \<18years
  • Pregnancy
  • Traumatic cardiac arrest
  • Arrest caused by hypovolaemia, tension or tamponade as determined by the clinical team on scene
  • Inability to secure a patent airway.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Arrest

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2024

First Posted

June 5, 2024

Study Start

September 1, 2024

Primary Completion

December 1, 2024

Study Completion

June 1, 2025

Last Updated

September 25, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share